| Post-Receptor IGF-1 Insensitivity Restricted to the MAPK Pathway in a Silver-Russell Syndrome Patient with Hypomethylation at the Imprinting Control Region on Chromosome 11. | |
| | |
MedLine Citation:
|
PMID: 22170793 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: Hypomethylation of the paternal imprinting center region 1 (ICR1) is the most frequent molecular cause of Silver-Russell syndrome (SRS). Clinical evidence suggests that patients with this epimutation have mild IGF-1 insensitivity.Objective: To assess in vitro IGF-1 action in fibroblasts culture from a SRS patient with IGF-1 insensitivity.Methods: Cultures of fibroblasts from one SRS patient with ICR1 demethylation and controls were established. The SRS patient has severe pre and postnatal growth failure, elevated IGF-1 level and no clear improvement in growth rate during rhGH treatment. IGF-1 action was assessed by cell proliferation, AKT and p42/44-MAPK phosphorylation. Gene expression was determined by real-time PCR.Results: Despite normal IGF-1R, fibroblast proliferation induced by IGF-1 was 50% lower in SRS fibroblasts in comparison to controls. SRS fibroblasts presented similar AKT but 65% decreased p42/44-MAPK phosphorylation. Expression of IGFBP-3 was significantly increased in SRS fibroblasts; however, there was no improvement in proliferation rate or MAPK pathway activation with desIGF-1, an analogue with low affinity for IGFBPs that retains the ability to activate IGF-1R. A PCR-array analysis disclosed a defect in MAPK pathway characterized by an increase of DUSP4 and MEF2C genes expression in patient fibroblasts.Conclusion: A post-receptor IGF-1 insensitivity was characterized in one SRS patient with ICR1 hypomethylation. Albeit our study was based on unique severely affected patient, it raises an intriguing possibility to explain the post-natal growth impairment observed in SRS patients. Analyses of larger cohorts are needed to explore the role of MAPK-pathway defect mediated growth failure in SRS. |
| | |
Authors:
|
Luciana Ribeiro Montenegro; Andrea Castro Leal; Debora Cabral Coutinho; Helena Panteliou Valassi; Mirian Yumie Nishi; Ivo Jp Arnhold; Berenice Bilharinho Mendonca; Alexander Augusto de Lima Jorge |
Related Documents
:
|
18403823 - A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparath... 9012693 - Clinical characteristics predict response to antithymocyte globulin in paroxysmal noctu... 15178513 - Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-14 |
Journal Detail:
|
Title: European journal of endocrinology / European Federation of Endocrine Societies Volume: - ISSN: 1479-683X ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9423848 Medline TA: Eur J Endocrinol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
L Montenegro, Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phase contrast MRI quantification of pulsatile volumes of brain arteries, veins, and cerebrospinal f...
Next Document: Fetuin A in non-alcoholic fatty liver disease: in vivo and in vitro studies.